Skip to main content
. 2015 Aug 4;7(8):6446–6464. doi: 10.3390/nu7085283

Table 3.

Effect of FA on metabolic variables and inflammatory cytokine.

Variables C + PG C + FA60 MS + PG MS + FA30 MS + FA60
FBG (mg/dL) 86.7 ± 1.4 87.2 ± 1.7 117.0 ± 3.4 * 100.4 ± 0.9 *# 93.4 ± 1.2 *#†
AUC (mg/dL/120 min) 14,597 ± 137 14,455 ± 433 17,609 ± 263 * 16,808 ± 273 *# 15,840 ± 248.4 *#†
HOMA-IR 1.73 ± 0.05 1.68 ± 0.67 17.85 ± 3.2 * 4.45 ± 0.44 *# 2.91 ± 0.26 *#†
Cholesterol (mg/dL) 58.1 ± 3.2 57.7 ± 2.2 87.6 ± 2.0 * 69.9 ± 1.3 *# 63.5 ± 4.2 *#
Triglycerides (mg/dL) 38.40 ± 6.15 36.14 ± 5.83 78.29 ± 3.96 * 50.60 ± 2.91 *# 49 ± 2.89 *#
HDL-C (mg/dL) 34.32 ± 1.54 34.33 ± 0.95 19.07 ± 1.55 * 33.29 ± 0.97 *# 33.50 ± 1.49 *#
Plasma TNF-α (pg/mL) 27.77 ± 3.15 25.83 ± 3.36 173.14 ± 16.30 * 52.98 ± 8.90 *# 42.02 ± 3.84 *#

C + PG: normal control rats received propylene glycol as a vehicle; C + FA60: normal control rats receiving ferulic acid 60 mg/kg; MS + PG: MS rats receiving propylene glycol; MS + FA30: MS rats receiving ferulic acid 30 mg/kg; MS + FA60: MS rats receiving ferulic acid 60 mg/kg. Values are expressed as mean ± standard error of the mean (SEM) (n = 10/group). * p < 0.05 vs. C + PG; # p < 0.05 vs. MS group; p < 0.05 vs. MS with FA 30 mg/kg. FBG, fasting blood glucose; AUC, area under the curve; HOMA-IR, homeostasis model assessment-estimated insulin resistance; HDL-C, high density lipoprotein-cholesterol; TNF-α, tumor necrosis factor-α.